Physicians remain wary of the wellness trend ...

In hormone receptor (HR)–positive, HER2-negative advanced breast cancer, starting CDK4/6 inhibitors (CDK4/6i) in the first line of therapy did not improve overall survival (OS) compared with reserving ...

USD 11.58 billion; 2031 Projected Market Size: USD 16.39 billion; CAGR (2026–2031): 7.2%; Chemiluminescence Immun ...

Roche Holding AG ( RHHBY) Discusses Phase III Study Results and Updates on Immunology Kidney Pipeline March 9, 2026 12:00 PM EDT ...

According to MarketsandMarkets, the Chemiluminescence Immunoassay Market is projected to grow from about USD 11.58 billion in 2026 to USD 16.39 ...

February 2026 proved to be a pivotal month for the oncology landscape, as the FDA green-lit several therapies targeting some ...

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q4 2025 Earnings Call Transcript March 5, 2026 TriSalus Life Sciences, Inc. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.13.

Dr. Kasey Holland Hamski, ND A case illustrating the interplay between EBV reactivation, environmental mold exposure, and immune dysregulation in a patient ...

Melanie Stein, ND Clinical improvement in treatment-refractory MCAS with normal conventional biomarkers and profound oral ...

Few topics provoke as much concern as the perception that puberty is beginning earlier than ever. While synthetic ...

MISSISSAUGA, Ontario, March 12, 2026--(BUSINESS WIRE)--As cargo theft and organized yard crime continue to challenge the trucking and transportation industries, Eagle Vision Security has announced the ...

SOFI shares have fallen 28% in six months, yet product launches, blockchain moves and strong growth forecasts highlight why ...